Skip to main content
. 2018 Feb 5;24:727–735. doi: 10.12659/MSM.908553

Figure 3.

Figure 3

The imatinib sensitivities of K562 cells and K562-R cells with or without VitaminK3 treatment under normoxia or hypoxia. (A) The cell activities of CML cells with imatinib treatment under normoxic or hypoxic conditions. The chemosensitivity of K562 (B) and K562-R (C) cells was improved by VitaminK3 stimulation in hypoxia. *** P<0.001; ** P<0.01; * P<0.05.